TargetIntegrin alpha-IIb/beta-3(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: >2.00E+4nMAssay Description:In vitro inhibition of human alphaIIb betaIIIa integrin binding in ELISAMore data for this Ligand-Target Pair